Grinspoon discusses recovery, addiction and whether psychedelics might have a role in addiction treatment.

Essence and Addiction

June 3, 2023 Lynne Nardizzi

Well said, Gabor Maté!

Ibogaine for Addiction?

December 2, 2022 Lynne Nardizzi

Supporters claim the powerfully hallucinogenic tree-bark derivative ibogaine can break the cycle of addiction and eliminate withdrawal.

Ibogaine comes from the iboga plant in Gabon, and is not legal in the US.

Psilocybin for Alcohol Addiction

August 30, 2022 Lynne Nardizzi

New research reveals that the psychedelic compound in magic mushrooms, in combination with talk therapy, could be a promising treatment for people with alcohol addiction.

In a study published Wednesday in JAMA Psychiatry, scientists found that patients taking this drug, called psilocybin, had an 83 percent decline in heavy drinking, while those who took a placebo experienced a 51 percent decline.

Kratom

August 17, 2021 Lynne Nardizzi

Kratom is used as an alternative to opioids, most commonly to treat pain or as a substitute for street drugs. The herb, formally known as Mitrogyna speciosa, has a centuries-long history of use in herbal medicine in Southeast Asia—notably as a substitute for opium.

Dosed Documentary

November 8, 2019 Lynne Nardizzi

Check out the documentary Dosed, from the Melbourne Documentary Film Festival 2019. Winner of Audience Award for Best Documentary.

Psychedelics, Addiction and Anxiety

October 25, 2019 Lynne Nardizzi

Here’s a look at how participants at some of the country's leading medical research centers are going through intense therapy and six-hour psychedelic journeys, deep into their minds, to help with addiction and anxiety.

Psilocybin Being Researched As Aid for Alzheimer's and Depression

September 7, 2019 Lynne Nardizzi

The largest psychedelic research center in the world, and the first of its kind in the United States, will open at Johns Hopkins Medicine in Maryland. Funded by $17 million from private donors, the Center for Psychedelic and Consciousness Research will conduct research into the use of psychedelic drugs in the treatment of addiction, PTSD, depression, Alzheimer's disease and more.